| | |
| China's antitrust probes not just aimed at foreign firms: official media Monday, Aug 26, 2013 08:44 PM PDT SHANGHAI (Reuters) - A series of antitrust investigations by Chinese regulators are part of efforts to toughen enforcement of a 2008 anti-monopoly law and are not just directed at foreign firms, the official China Daily reported on Tuesday. Some foreign executives in China have said recent high-profile probes into the milk powder and pharmaceutical sectors appeared to show foreign companies were being singled out. ... Full Story | Top |
| Tropical depression Fernand kills 13 in Mexico, dissipates Monday, Aug 26, 2013 05:26 PM PDT | Top |
| Onyx deal expected to give Amgen a big boost Monday, Aug 26, 2013 04:05 PM PDT By Susan Kelly (Reuters) - Investors reacted favorably on Monday to Amgen Inc's $10.4 billion purchase of Onyx Pharmaceuticals Inc, which gives the world's largest biotech company full rights to a blood cancer drug with multibillion-dollar sales potential. Amgen shares rose 9 percent in midday trade on news of the acquisition, the biggest biotech deal since Gilead Sciences Inc's $11 billion purchase of Pharmasset in 2012. The main prize in the acquisition is Onyx's blood cancer drug Kyprolis. ... Full Story | Top |
| Acura's abuse-deterrent pain drug fails mid-stage study goal Monday, Aug 26, 2013 03:23 PM PDT By Vrinda Manocha (Reuters) - Acura Pharmaceuticals Inc said a painkiller made with its abuse-deterrent technology did not show statistically significant results in reducing likability among abusers, sending its shares down as much as 34 percent in extended trading. The mid-stage study showed that Acura's tablet, being tested for potential abuse by snorting, had a slightly lower measure of liking when compared with the generic hydrocodone/acetaminophen tablet. ... Full Story | Top |
| U.S. data, Syria push TSX off three-month high Monday, Aug 26, 2013 02:29 PM PDT By John Tilak and Rod Nickel TORONTO (Reuters) - Canada's main stock index ended little changed on Monday after political tension in Syria and sluggish U.S. economic data weighed on sentiment, offsetting gains made by producers of gold and fertilizer on a jump in commodity prices. The Toronto market's benchmark index eased from the three-month high it hit earlier in the session after U.S. Secretary of State John Kerry said the Syrian government was trying to cover up evidence of a deadly chemical attack, signaling the United States was edging closer to a possible military response. ... Full Story | Top |
| Congo army battles M23 rebels near eastern city of Goma Monday, Aug 26, 2013 02:19 PM PDT By Kenny Katombe GOMA, Democratic Republic of Congo (Reuters) - A U.N. brigade tasked with neutralizing armed groups in Congo has assisted the country's army in clashes with eastern rebels on Monday, ending a brief lull in days of fighting that has killed and wounded dozens. The violence, the most serious in months, is the first major test for the newly deployed U.N. Intervention Brigade which has an unprecedented mandate to launch military operations against M23, one of the rebels at the heart of nearly two decades of conflict. A senior officer with the brigade told Reuters that U.N. ... Full Story | Top |
| Pennsylvania girl who sued for lung transplants to leave hospital Monday, Aug 26, 2013 02:09 PM PDT PHILADELPHIA (Reuters) - An 11-year-old Pennsylvania girl whose parents filed a lawsuit challenging national transplant policies so she could receive two lung transplants will be released from the hospital on Tuesday, a spokeswoman for her family said on Monday. The girl, Sarah Murnaghan, underwent an operation earlier this summer to receive the transplants in a case that set off a national debate about child access to organ donations. She had earlier been diagnosed with cystic fibrosis. A federal judge cleared the way for the operation in June after her parents sued to stop the U.S. ... Full Story | Top |
| New Jersey to build storm-resilient grid for its transit system Monday, Aug 26, 2013 01:10 PM PDT NEW YORK (Reuters) - The Department of Energy and the state of New Jersey announced plans on Monday to design a small electric grid that will serve the state's transit system and withstand the onslaught of storms like Superstorm Sandy. The micro grid will power the transit system's rail operations between Newark, Jersey City and Hoboken in New Jersey. It will be designed by the energy department's Sandia National Laboratories, which has worked on such grids for the U.S. military. The cost and start date of the project were not announced. ... Full Story | Top |
| Tropical depression Fernand kills 13 as it weakens over Mexico Monday, Aug 26, 2013 12:21 PM PDT | Top |
| Fukushima operator to seek foreign advice on toxic water Monday, Aug 26, 2013 11:14 AM PDT | Top |
| South Sudan passes oil bill, waits president's approval Monday, Aug 26, 2013 10:18 AM PDT | Top |
| Exchange operators BATS and Direct Edge to merge Monday, Aug 26, 2013 09:31 AM PDT By John McCrank (Reuters) - BATS Global Markets Inc and Direct Edge Holdings said on Monday they would merge, in a deal that would create the second-largest U.S. stock exchange operator after NYSE Euronext . The stock trading business has been in decline for more than three years, as uncertainty over the global economy pushed retail investors to the sidelines and low market volatility hit volumes. Exchange operators have been looking for new sources of revenue, including in areas of market data and technology. They have also been trying to combine to create scale and take out costs. ... Full Story | Top |
| Syria chemical evidence fades as U.N. team under fire Monday, Aug 26, 2013 08:15 AM PDT | Top |
| Rigel drops asthma drug after trial fails, stock hits life-low Monday, Aug 26, 2013 07:44 AM PDT (Reuters) - Rigel Pharmaceuticals Inc said it will stop developing its experimental asthma drug after the therapy failed in a mid-stage trial, sending its shares down as much as 17 percent to a life-low. The failure of the inhaled drug is the latest blow to the company's pipeline after its partner AstraZeneca pulled out of developments of their rheumatoid arthritis pill in June. The inhaled asthma drug, R343, was being tested as a treatment for patients with allergic asthma, but failed to meet any of its goals, including improving lung function. ... Full Story | Top |
| Finance chief of South Africa's Sasol to step down next month Monday, Aug 26, 2013 04:31 AM PDT JOHANNESBURG (Reuters) - South African petrochemicals company Sasol Ltd said on Monday its chief financial officer will step down next month after seven years with the company. Christine Ramon's last day at Sasol will be on September 9, when the company releases its full-year results. Paul Victor, an executive in the group's finance division, has been appointed acting CFO, Sasol said. Full Story | Top |
|

No comments:
Post a Comment